Volume 4 Supplement 1

Proceedings of the 13th International Transplantation Symposia: mTOR-inhibition: what have we learned and how do we best apply the learning


The symposium and publication were supported by an unrestricted educational grant from Pfizer Inc, who had no influence on the editorial content. Editorial support was provided by Synergy, Richmond, UK and was funded by Pfizer Inc. The articles have been through the journal's standard peer review process.

Rome, Italy

22-23 April 2013

Edited by Edward Geissler and Alan Jardine

  1. Review

    Reviewing 15 years of experience with sirolimus

    Here, we review 15 years of clinical use of sirolimus in our transplant center, in context with the developing immunosuppressive strategies use worldwide. The majority of studies were conducted in de novo kidn...

    Helio Tedesco Silva Jr, Claudia Rosso Felipe and Jose Osmar Medina Pestana

    Transplantation Research 2015 4(Suppl 1):28

    Published on: 22 December 2015

  2. Review

    Practical considerations for the use of mTOR inhibitors

    Immunosuppressive therapy after kidney transplantation is based on calcineurin inhibitors (CNI). In most cases CNI therapy is combined with mycophenolate and steroids. In spite of good short-term results this ...

    Fritz Diekmann and Josep M. Campistol

    Transplantation Research 2015 4(Suppl 1):29

    Published on: 22 December 2015